Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableLooking for participantsNCT06642324
What this trial is testing

Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas

Who this might be right for
Head Neck CancerOropharyngeal Neoplasms
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 550
Testing effectiveness (Phase 2)Looking for participantsNCT05419089
What this trial is testing

The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)

Who this might be right for
HPV-positive Oropharyngeal Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai 83
Testing effectiveness (Phase 2)Study completedNCT02258659
What this trial is testing

Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer

Who this might be right for
Human Papilloma Virus InfectionStage III Squamous Cell Carcinoma of the OropharynxStage IVA Squamous Cell Carcinoma of the Oropharynx+1 more
University of Chicago 62
Not applicableActive Not RecruitingNCT05814549
What this trial is testing

A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)

Who this might be right for
Oropharyngeal CancerHPV-Related CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Temporarily pausedNCT06254911
What this trial is testing

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

Who this might be right for
Oropharynx Cancer, Stage I
Emory University 20
Testing effectiveness (Phase 2)Study completedNCT01530997
What this trial is testing

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

Who this might be right for
Carcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal Neoplasms
UNC Lineberger Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT06702033
What this trial is testing

The Minimalist Trial-2

Who this might be right for
HPV-Related Oropharynx Squamous Cell Carcinoma
Washington University School of Medicine 142
Testing effectiveness (Phase 2)Study completedNCT04180215
What this trial is testing

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Hookipa Biotech GmbH 198
Early research (Phase 1)Active Not RecruitingNCT05973487
What this trial is testing

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more
TScan Therapeutics, Inc. 840
Not applicableEnded earlyNCT05061940
What this trial is testing

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Who this might be right for
Head and Neck CancerMelanomaHPV-Related Malignancy+5 more
Repertoire Immune Medicines 22
Early research (Phase 1)Not Yet RecruitingNCT05582590
What this trial is testing

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

Who this might be right for
Oropharyngeal CancerHuman Papilloma VirusHead and Neck Cancer+8 more
NexImmune Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT05307939
What this trial is testing

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Who this might be right for
HPVOropharynx CancerHPV-Related Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT02281955
What this trial is testing

De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study

Who this might be right for
Carcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal Neoplasms
UNC Lineberger Comprehensive Cancer Center 115
Testing effectiveness (Phase 2)Looking for participantsNCT05686226
What this trial is testing

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Who this might be right for
Cervical CancerThroat CancerOropharynx Cancer+18 more
Christian Hinrichs 20
Testing effectiveness (Phase 2)Looking for participantsNCT06636734
What this trial is testing

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown PrimaryMetastatic Head and Neck Squamous Cell Carcinoma+19 more
Emory University
Testing effectiveness (Phase 2)UnknownNCT04920344
What this trial is testing

Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+1 more
Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)Study completedNCT03623646
What this trial is testing

Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial.

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
Institut Claudius Regaud 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06505551
What this trial is testing

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

Who this might be right for
HPV-Related Squamous Cell CarcinomaHPV-Related Cervical Squamous Cell CarcinomaHPV-Related Vulvar Squamous Cell Carcinoma+4 more
SCG Cell Therapy Pte. Ltd. 66
Testing effectiveness (Phase 2)Study completedNCT02858310
What this trial is testing

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Who this might be right for
Papillomavirus InfectionsCervical Intraepithelial NeoplasiaCarcinoma In Situ+2 more
National Cancer Institute (NCI) 224
Testing effectiveness (Phase 2)Active Not RecruitingNCT05232851
What this trial is testing

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related CarcinomaLocally Advanced Oropharyngeal Carcinoma+2 more
Mayo Clinic 20
Load More Results
28
15